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5 patient cohorts and can be used to improve clinical decision making in
Irish men under investigation for PCa.
0187: SINGLE CENTRE EXPERIENCE FROM THE ACCURACY OF
CONVENTIONAL 1.5 T MAGNETIC RESONANCE IMAGING FOR THE
DIAGNOSIS AND PRE-OPERATIVE STAGING OF PROSTATE CANCER
H. Raja*, D. Moschonas, N. Haldar, K. Misra, J. Kelleher. Buckinghamshire
Hospitals NHS Trust, UK
Aim: Not all trusts in the UK have 3T MRI scanners. Are patients with
suspected prostate cancer therefore adequately staged with a more con-
ventional 1.5T MRI scanner? The aim of the study was to evaluate the
accuracy of standard 1.5T MRI without endorectal coil for the staging of
prostate cancer compared against the histopathological results following
radical prostatectomy.
Methods: Prospective study enrolled 65 patients with biopsy-proven PCa
who underwent MRI prior to undergoing radical prostatectomy from
December 2012 to June 2014.
Results: Median times for patients having an MRI scan after TRUS biopsy
were 32.5 days. Preoperatively 38.5% of patients were diagnosed with T3/
T4 disease with MRI. The prevalence of pT3 and above prostate cancer
conﬁrmed histologically was 22/65 (33.84%). Postoperative down staging
was documented in 12/65 (18.46%) while upstaging in 9/65 (13.85%). The
sensitivity of MRI diagnosing T3 disease was 14/22 (63.63%), speciﬁcity 29/
43 (67.44%), accuracy 43/65 (66.15%)
Conclusion: Standard MRI detected 63.63% of all patients with T3 pros-
tate cancer, a crucial feature when planning deﬁnitive treatment. The
promising detection rate of our study, while being operator dependent,
offers a cost effective imaging modality for preoperative staging of
prostate cancer.
0188: A COMPARISON OF LEARNING CURVES IN ROBOTIC
PROSTATECTOMY WITHIN A CHANGING REFERRAL PRACTICE
A. Srinivasan 2,*, N.C. Shah 1, D.E. Neal 1, V.J. Gnanapragasam 1. 1Cambridge
University Hospitals Trust, UK; 2University of Cambridge, UK
Aim: Increased numbers of high-risk patients with advanced disease are
being treated with robotic prostatectomy (RP). We have explored the
impact of this on the learning curves and pathological outcomes of three
surgeons in a single RP tertiary unit.
Methods: Data was sourced from a prospective database and a previous
publication from our unit. Three periods corresponding to the ﬁrst and
second 50 cases of three surgeons (A: 2005-2006, B: 2008-2009, C: >2010)
were interrogated. One surgeon, (A), had prior extensive open RP
experience.
Results: Low-risk disease represented 55%, 33% and 25% of referrals in
periods A, B and C respectively while high-risk referrals accounted for 10%,
15% and 24% (p¼0.0001). Analysing cases 1-50 demonstrated declining
numbers of pT2 cases (A:74%, B:60% and C:46%) but an increase in pT3a
cases (A: 22%, B:34% and C:48%) and ﬁnal tumour volumes (A:9%, B:8% and
C:22%) (p¼0.002). Comparing cases 51-100 revealed identical trends.
Positive surgical margin (PSM) rates for cases 1-50 were A:12%, B:20% and
C:23% (p¼0.12). For cases 51-100 there was again no signiﬁcant difference
in PSM rates.
Conclusion: There is an increasing risk proﬁle amongst referred patients
which has however had minimal impact on pathological outcomes during
temporally different learning curves.
0237: PRESENCE OF DETRUSOR MUSCLE IN BLADDER TUMOUR
RESECTION: THE ROLE OF OPERATOR EXPERIENCE
S.M. Lee*, A. Russell, G. Hellawell. Northwick Park Hospital, UK
Aim: Detrusor muscle (DM) in transurethral resection of bladder
tumour (TURBT) specimens is a surrogate maker for resection quality.
Studies have suggested a correlation with the level of operating sur-
geon. We audited tumour and surgical factors related to detrusor
muscle sampling.Methods: Retrospective review of TURBT cases from 01/2011-01/2014 in a
district hospital. Demographics, tumour and surgical characteristics were
collected and analysed.
Results: 179 patients were included (mean age 71.2±12.2 years, mal-
e:female 141:38). Senior surgeons performed 129 (72.1%) resections. All
TURBTs were performed on dedicated lists with a senior surgeon super-
vising. DM was present in 140 (78.2%) samples. Within the cohort, there
was no signiﬁcant difference in recurrence rate when DMwas not sampled
(OR 1.315, 95%CI 0.617-2.805, p¼0.479).
Demographics for junior/senior surgeons signiﬁcantly differed for ASA
Grade, tumourmultiplicity and location. No difference in DM resectionwas
identiﬁed between junior/senior surgeons. Univariate analysis identiﬁed
that DM was less likely to be sampled in high grade (G3) tumours (versus
G1/G2, OR 0.345,p¼0.018*).
Conclusion: In contrast to previous studies, DM resection rates were not
inﬂuenced by surgeon level. Impact of operator experience may be miti-
gated through the use of dedicated TURBT lists and direct senior super-
vision, although further investigation is needed.
0239: VALIDATION OF INFLAMMATION-BASED PROGNOSTIC SCORES
AND HAEMATOLOGICAL PARAMETERS TO PREDICT BLADDER CANCER
INVASION
S.M. Lee*, A. Russell, G. Hellawell. Northwick Park Hospital, UK
Aim: There is increasing evidence that inﬂammation plays a role in cancer
development. We aimed to compare the predictive value of inﬂammation-
based prognostic scores and haematological values in differentiating non-
muscle invasive (NMIBC) and muscle invasive (MIBC) bladder cancer.
Methods: Bladder cancer cases from 01/2011-12/2013 were analysed
retrospectively. Patient/tumour characteristics, prognostic scores
(Neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR) and platelet-
to-lymphocyte ratio (PLR)) and haematology results were analysed.
Results: 227 patients were included: 176 and 51 in the NMIBC and MIBC
groups, respectively. Groups were signiﬁcantly different (p<0.05) with
regards to age, tumour grade, size, NLR, dNLR, PLR, albumin and white cell,
neutrophil, lymphocyte and platelet counts.
Of the prognostic scores, dNLR (threshold>2.32) had the greatest area
under the ROC curve of 0.725 (Sensitivity 56.9%, Speciﬁcity 79.4%) as
compared to NLR (0.710) and PLR (0.642) and was included in multivariate
analysis. Mean dNLR was 1.86±0.85 in NMIBC and 2.95±2.04 in MIBC.
Multivariate logistic regression analysis identiﬁed tumour grade (OR
19.968, 95%CI 5.008-79.614, p<.0001*) and dNLR (OR 2.260, 95%CI 1.032-
4.947, p¼0.041*) as independent predictors of MIBC.
Conclusion: Our comparison indicates that dNLR may provide a simple,
cost-effective marker for MIBC that can be performed at time of cystos-
copy, thereby assisting in treatment planning.
0259: HOSPITAL ADMISSIONS WITH SEPSIS AFTER TRUS-GUIDED
PROSTATE BIOPSY: ITS INCIDENCE AND BACTERIAL CHARACTERISTICS
IN BOLTON, UK
Z. Zhou*, K. Edwards, M. Pantelides. Royal Bolton Hospital, UK
Aim: Transrectal ultrasound (TRUS)-guided prostate needle biopsy is a
diagnostic procedure for prostate cancer. We aim to investigate incidence
and bacterial characteristics of post-biopsy sepsis.
Methods: A retrospective analysis of medical records was performed in
1105 patients that underwent a 12-core TRUS-guided prostate biopsy at
our hospital over a ﬁve-year period from January 2009 to December 2013.
Cases in which patients admitted with sepsis within 14 days after the bi-
opsy were investigated.
Results: Overall, 20 out of 1105 patients (1.81%) were admitted with sepsis
within 7±3.68 days after the biopsy. All patients received ciproﬂoxacin
prophylaxis for 3 days. 15 patients (1.36%) had positive microbial culture.
Escherichia coli (E. coli) grew in samples from 9 patients (60%), Entero-
coccus species in 2 patients (13.3%), non-E. coli coliforms in 5 patients
(33.3%).One patient had different bacteria cultured from urine and blood
samples. Fluoroquinolone-resistant bacteria were conﬁrmed in 10 patients
(62.5%). Resistance to trimethoprim, co-amoxiclav and tazocin was 43.8%,
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Two cases of E. coli had extended-spectrum b-lactamase activity.
Conclusion: E. coli appears to be the most common cause of sepsis post
prostate biopsy. An intravenous tazocin or carbapenem-based therapy
seems to provide satisfying antimicrobial cover.
0264: MULTIMODAL SEQUENTIAL TREATMENT OF SMALL RENAL
MASSES WITH ARTERIAL EMBOLISATION AND RADIOFREQUENCY
ABLATION
A. Downey*, D. Curry, A. Thwaini. Belfast City Hospital, Belfast, UK
Aim: Radiofrequency ablation (RFA) is a treatment option for small renal
masses (SRMs) in patients unsuitable for radical therapy. Recognised
complications are residual tumour, recurrence and haemorrhage.
Sequential combination therapy with arterial embolisation and RFA can
potentially reduce these complications. We assessed the initial results of
this treatment in our centre.
Methods: Data was collected retrospectively on patients undergoing
embolization and RFA between 2009-2012 including co-morbidities,
tumour characteristics and renal function pre and post treatment. Mean
follow-u period was 25.9 months. Effect of treatment was assessed on
follow-up imaging at 1 month and subsequent deﬁned intervals.
Results: 16 patients were identiﬁed with a mean age of 64 (Range 47-
76) and mean Charlson co-morbidity index of 5(Range 2-9). All patients
had solitary non-metastatic tumours with maximal tumour diameter
ranging from 1.5-5cm. Two patients had solitary kidneys due to previ-
ous RCC.
Mean creatinine was 101umol/L(Range 64-203) pre-procedure and
113(Range 64-269) post-procedure (p¼0.174). 6/16(38%) patients had a
deterioration in eGFR.
3/16(18.7%) patients required salvage RFA. One patient required two
salvage treatments and one underwent laparoscopic nephrectomy for
tumour enlargement. No disease related deaths were recorded.
Conclusion: Our study suggests that treatment of SRMs with sequential
embolization and RFA is both safe and efﬁcacious.
0346: ADULT MALE CIRCUMCISION UNDER LOCAL ANAESTHETIC: AN
UNDER-UTILISED BUT SAFE AND EFFECTIVE ALTERNATIVE
R. Kenny, O. Muoka*, A. Simpson. United Lincolnshire NHS Trust, UK
Aim: In the United Kingdom over 30,000 circumcisions take place per year,
traditionally performed under General Anaesthetic (GA). Local Anaesthetic
(LA) has been shown in literature to be a safe alternative with excellent
analgesic outcomes.
Methods: A prospective audit over 18 months identiﬁed 26 patients as
suitable and willing candidates to undergo LA circumcision. Patients were
asked to record their pain score via a Visual Analogue score chart (VAS)
both during and 90 minutes post-procedure, 0 ¼ no pain, 10 ¼worst pain.
LA used was 10mls of 1% lidocaine + 10mls of 0.5% bupivacaine as routine,
with 1% lidocaine used as top-up if required.
Results: No patients suffered procedural complications. The mean agewas
64.9 years: 42.5% of patients were ASA-3, 46.2% ASA-2 and 11.5% ASA-1.
Only 26.9% needed Top-up LA. 73% of patients had an intraoperative VAS
score of 0. All patients were pain-free post-operatively.
Conclusion: LA circumcision is a safe and effective alternative to GA
circumcision in adult males, with excellent analgesic proﬁle both intra-
operatively and post-procedure. Avoidance of a GA has multiple beneﬁts
for both the patient and surgical institution.
0417: BLADDER CANCER-TUMOR BANK: THE CORNERSTONE OF
NATIONAL AND INTERNATIONAL BASIC RESEARCH IN BLADDER CANCER
E. Sultan 1, E.Eid Badr 1, A. Magdy 1, A. El sayed 1, B. Ibrahim 2,*, N.
Mohamed 1, A. Elkashash 1, A.M. Shahin 1, H.K. Salem 1. 1Cairo University,
Egypt; 2 Swiss Canal University, Egypt
Aim: Tumor banks have the primary responsibility for collecting, cata-
loging, storing and disseminating samples of tissues, cells and ﬂuids,
which are used by researchers to identify diagnostic molecular markers,prognostic indicators and therapeutic targets. Our aim was to describe a
simple, reliable and reproducible protocol for obtaining and storing sam-
ples of bladder cancer tumors.
Methods: Bladder cancer tumor tissues were obtained by the surgeons
after endoscopic resection or after radical cystectomy. The obtained sur-
gical specimens were immediately placed in liquid nitrogen, and then
stored by cryopreservation (-80C). A nother fragment was ﬁxed in 10%
formalin. For each patient, urine sample, blood sample, and serum sample
were obtained and preserved for future research.Complete clinical data
regarding the patient history, investigations, operative details and follow
up details were recorded.
Results: We have till now 300 bladder cancer samples cryopreserved. For
each patient, complete data sheet, pathology block, slide containing tumor
print, 5-6 +ve charged unstained slides, and H/E stained slides repre-
senting the pathological features of the tumour including the histo path-
ological subtype ,stage, grade , and micro vascular invasion.
Conclusion: This protocol provides an important tool facilitating methods
of diagnosis and treatment of bladder cancer. National and international
multi centre research protocols for this ﬁeld are encouraged.
0421: ANTICOAGULANTS & HAEMATURIA: THE CLINICAL AND
ECONOMIC BURDEN OF ANTICOAGULANTS ON EMERGENCY UROLOGY
ADMISSIONS
D. Conaway*, V. Lavin, A. Thorpe. Freeman Hospital, UK
Aim: Anticoagulant prescriptions are rising with new medications
increasingly popular. This study focusses on the urological side effects of
anticoagulants. Our aims were to determine: the prevalence of emergency
haematuria admissions, which anticoagulants are prescribed in these pa-
tients, what inpatient management is required, and the economic cost of
such admissions.
Methods: This was a retrospective study examining all emergency ad-
missions at one urology centre over a ten month period. Digital records
were examined for patients' medications, operation records and in-
vestigations performed. Cost analysis was performed in discussion with
the base hospital.
Results: 106 patients produced 138 total emergency admissions with
haematuria. 60 patients were taking1 anticoagulant. Aspirin, clopidogrel
and warfarin were the most common anticoagulants prescribed. 64.4% of
admissions required bladder irrigation and 63% required ﬂexible cystos-
copy.11 patients required emergency surgery. The cost of these admissions
to the hospital was over £90,000.
Conclusion: This study showed that the majority of haematuria admis-
sions were associated with anticoagulant use. ‘Traditional' anticoagulants
were the most commonly used; however, newer anticoagulants such as
rivaroxabanwere associated with longer inpatient stays, likely due to their
irreversibility. Previous research suggests up to one third of anticoagulant
prescriptions are inappropriate, which offers signiﬁcant potential savings.
0421: TOTAL PELVIC EXENTERATION FOR LOCALLY ADVANCED (T4)
BLADDER CANCER: A SINGLE CENTRE EXPERIENCE
R. Radwan*, M. Gallagher, R. Chaytor, J. Featherstone, P. Bose. Morriston
Hospital, UK
Aim: Total pelvic exenteration is an effective procedure in colorectal and
gynaecological malignancies, but its role in advanced bladder cancer is not
well documented. Our aim was to review surgical outcomes of all patients
following total pelvic exenteration at our institute.
Methods: A retrospective review of all patients who underwent total
pelvic exenteration for bladder malignancy between 1992-2014 was per-
formed. Data on patient demographics, staging, surgical complications,
postoperative histology, follow up and survival rates were collected.
Results: A total of 11 patients were included in the study with a median
age of 68 years. 9 procedures were carried out for locally advanced primary
carcinoma and 2 for recurrent disease. Clear resection margins were
achieved in 6 (54.5%) patients. 4 patients developed signiﬁcant post-
operative complications and median length of hospital stay was 18 days.
No deaths were reportedwithin 90 days of surgery. Median survival was 11
months and 5 year survival rate was 18%.
